Skip to main content
SpringerLink
Log in

Heparin-Induced Thrombocytopenia and Alternatives to Heparin

  • Chapter
  • First Online:
Evidence-Based Practice in Perioperative Cardiac Anesthesia and Surgery

  • 1441 Accesses

Abstract

Heparin-induced thrombocytopenia (HIT) refers to platelet count reduction that occurs when patients receive heparin therapy, and is a common occurrence in perioperative cardiac surgery patients. This chapter discusses the perioperative considerations regarding thrombocytopenia, including assessing likelihood of occurrence, serological testing, and management options for the patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):311S–37S.

    Article  CAS  Google Scholar 

  2. Warkentin TE. Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia. Thromb Haemost. 2016;116(5):813–22.

    Google Scholar 

  3. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006;4(4):759–65.

    Article  CAS  Google Scholar 

  4. Shore-Lesserson L, Baker RA, Ferraris VA, et al. The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines—Anticoagulation During Cardiopulmonary Bypass. Anesth Analg. 2018;126(2):413–24.

    Article  Google Scholar 

  5. Sachan D, Gupta N, Chaudhary R. Rapid diagnosis of heparin-induced thrombocytopenia using a particle gel immunoassay in at-risk cardiac surgery patients. Asian J Transfus Sci. 2013;7(1):92–3.

    Article  Google Scholar 

  6. Bennett-Guerrero E, Slaughter TF, White WD, Welsby IJ, Greenberg CS, El-Moalem H, et al. Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery. J Thorac Cardiovasc Surg. 2005;130(6):1567–72.

    Article  CAS  Google Scholar 

  7. Kress DC, Aronson S, McDonald ML, Malik MI, Divgi AB, Tector AJ, et al. Positive heparin-platelet factor 4 antibody complex and cardiac surgical outcomes. Ann Thorac Surg. 2007;83(5):1737–43.

    Article  Google Scholar 

  8. Warkentin TE, Arnold DM, Nazi I, Kelton JG. The platelet serotonin-release assay. Am J Hematol. 2015;90(6):564–72.

    Article  CAS  Google Scholar 

  9. Warkentin TE, Sheppard JA, Chu FV, Kapoor A, Crowther MA, Gangji A. Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities. Blood. 2015;125(1):195–8.

    Article  CAS  Google Scholar 

  10. Agarwal S, Ullom B, Al-Baghdadi Y, Okumura M. Challenges encountered with argatroban anticoagulation during cardiopulmonary bypass. J Anaesthesiol Clin Pharmacol. 2012;28(1):106–10.

    Article  Google Scholar 

  11. Anand SX, Viles-Gonzalez JF, Mahboobi SK, Heerdt PM. Bivalirudin utilization in cardiac surgery: shifting anticoagulation from indirect to direct thrombin inhibition. Can J Anaesth. 2011;58(3):296–311.

    Article  Google Scholar 

  12. Welsby IJ, Um J, Milano CA, Ortel TL, Arepally G. Plasmapheresis and heparin reexposure as a management strategy for cardiac surgical patients with heparin-induced thrombocytopenia. Anesth Analg. 2010;110(1):30–5.

    Article  CAS  Google Scholar 

  13. Palatianos GM, Foroulis CN, Vassili MI, Matsouka P, Astras GM, Kantidakis GH, et al. Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost. J Thorac Cardiovasc Surg. 2004;127(2):548–54.

    Article  Google Scholar 

  14. Palatianos G, Michalis A, Alivizatos P, Lacoumenda S, Geroulanos S, Karabinis A, et al. Perioperative use of iloprost in cardiac surgery patients diagnosed with heparin-induced thrombocytopenia-reactive antibodies or with true HIT (HIT-reactive antibodies plus thrombocytopenia): an 11-year experience. Am J Hematol. 2015;90(7):608–17.

    Article  CAS  Google Scholar 

  15. Koster A, Kukucka M, Bach F, Meyer O, Fischer T, Mertzlufft F, et al. Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban. Anesthesiology. 2001;94(2):245–51.

    Article  CAS  Google Scholar 

  16. Greinacher A. Heparin-induced thrombocytopenia. N Engl J Med. 2015;373(3):252–61.

    Article  CAS  Google Scholar 

  17. Cuker A, Gimotty PA, Crowther MA, Warkentin TE. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood. 2012;120(20):4160–7.

    Article  CAS  Google Scholar 

  18. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med. 2001;344(17):1286–92.

    Article  CAS  Google Scholar 

  19. Dyke CM, Smedira NG, Koster A, Aronson S, McCarthy HL 2nd, Kirshner R, et al. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study. J Thorac Cardiovasc Surg. 2006;131(3):533–9.

    Article  CAS  Google Scholar 

  20. Merry AF. Bivalirudin, blood loss, and graft patency in coronary artery bypass surgery. Semin Thromb Hemost. 2004;30(3):337–46.

    Article  CAS  Google Scholar 

  21. Smedira NG, Dyke CM, Koster A, Jurmann M, Bhatia DS, Hu T, et al. Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study. J Thorac Cardiovasc Surg. 2006;131(3):686–92.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Zucker School of Medicine at Hofstra Northwell, Northwell Health System, Northshore University Hospital, Manhasset, NY, USA

    Linda Shore-Lesserson

  2. Anesthesia and Perioperative Medicine, Medical University of South Carolina, Charleston, SC, USA

    Alan Finley

Authors
  1. Linda Shore-Lesserson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alan Finley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Linda Shore-Lesserson .

Editor information

Editors and Affiliations

  1. Distinguished University Professor Department of Anesthesia and Perioperative Medicine and Department of MedicineDivision of Critical Care Medicine, London Health Sciences Center and St Joseph’s Healthcare London Centre for Medical Evidence, Decision Integrity and Clinical Impact (MEDICI) Western University, London, ON, Canada

    Davy C.H. Cheng

  2. Associate Professor Department of Anesthesia and Perioperative Medicine and Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Centre for Medical Evidence, Decision Integrity and Clinical Impact (MEDICI) Western University, London, ON, Canada

    Janet Martin

  3. Professor of Surgery University of Toronto, Melanie Munk Chair of Cardiovascular Surgery University Health Network, Toronto, ON, Canada

    Tirone David

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Shore-Lesserson, L., Finley, A. (2021). Heparin-Induced Thrombocytopenia and Alternatives to Heparin. In: Cheng, D.C., Martin, J., David, T. (eds) Evidence-Based Practice in Perioperative Cardiac Anesthesia and Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-47887-2_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-47887-2_25

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-47886-5

  • Online ISBN: 978-3-030-47887-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation